HUM Q4 2025 Earnings Call Summary

Humana Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

Adjusted EPS: Reported at $17.14, exceeding initial guidance of approximately $16.25.
Membership Growth: Increased by 1 million members or 20% during the Annual Enrollment Period (AEP).
Retention Rate: Improved by over 500 basis points year-over-year.
Benefit Ratio: Full-year insurance segment benefit ratio at 90.4%, slightly better than guidance.
2026 Adjusted EPS Guidance: Expected to be at least $9, with a projected decline due to STARS headwinds.

2. Strategic Updates and Business Highlights

Consumer-Centric Strategy: Continued commitment to enhancing member experience and clinical outcomes.
Operational Capacity: Positive early indicators for onboarding new members, including reduced complaints and improved customer service metrics.
Medicaid Expansion: Growth in Medicaid services now spans 13 states, with new launches anticipated in Georgia and Texas.
CenterWell Growth: Significant tailwinds expected from CenterWell Pharmacy and home health services due to new membership.

3. Forward Guidance and Outlook

2026 Membership Growth: Anticipated growth of approximately 25% in individual Medicare Advantage (MA) membership.
Margin Expectations: Expected doubling of individual MA margin year-over-year when normalizing for STARS.
Long-term Goals: Aiming to unlock earnings potential by 2028, with a focus on maintaining a stable and compelling margin.

4. Bad News, Challenges, or Points of Concern

STARS Headwinds: Expected net STARS headwind of approximately $3.5 billion for 2026, impacting margins significantly.
Operational Risks: Concerns regarding the ability to absorb new membership growth without compromising service quality.
Rate Notice Uncertainty: Ongoing uncertainties related to Medicare Advantage funding, with potential adjustments needed based on final rate notices.
Competitive Pressures: Notable competition in the market, particularly regarding member retention and acquisition strategies.

5. Notable Q&A Insights

Earnings from Non-MA Segments: CenterWell's growth is expected to contribute positively to overall earnings, offsetting some of the challenges in MA underwriting.
Member Cohort Margins: New members are expected to have similar margins to existing cohorts, despite STARS headwinds, due to lower acquisition costs and ongoing medical management improvements.
Value-Based Care: Approximately one-third of MA members are in full-risk contracts, with ongoing efforts to enhance partnerships with value-based providers.
Investment Strategy: Humana plans to maintain investments in technology and operational efficiency while being mindful of spending, particularly in light of STARS impacts.

This summary encapsulates the key points from Humana's Q4 2025 earnings call, highlighting both the positive developments and the challenges faced by the company as it navigates a dynamic healthcare landscape.

HUM — Humana Inc.